ZNF22 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 7.57190000000296E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
1.075400E-03
Normal-vs-Stage2
2.05089999999464E-05
Normal-vs-Stage3
2.014500E-04
Normal-vs-Stage4
4.648400E-02
Stage1-vs-Stage2
9.589600E-01
Stage1-vs-Stage3
3.286200E-01
Stage1-vs-Stage4
2.962800E-01
Stage2-vs-Stage3
3.789200E-01
Stage2-vs-Stage4
2.066400E-01
Stage3-vs-Stage4
1.228400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
9.70809999999434E-05
Normal-vs-AfricanAmerican
3.397500E-03
Normal-vs-Asian
7.436100E-04
Caucasian-vs-AfricanAmerican
7.464400E-01
Caucasian-vs-Asian
8.416300E-02
AfricanAmerican-vs-Asian
1.919610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
1.782760E-04
Normal-vs-Female
4.4829000000024E-05
Male-vs-Female
2.277800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
8.321200E-03
Normal-vs-Age(41-60Yrs)
1.176100E-04
Normal-vs-Age(61-80Yrs)
2.033700E-04
Normal-vs-Age(81-100Yrs)
1.11169999994498E-06
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.115200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.732800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.133400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.043800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.804300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.666800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
3.37470000000284E-06
Normal-vs-Daily Drinker
1.53257999999656E-05
Normal-vs-Weekly Drinker
2.39619999999885E-05
Normal-vs-Occasional Drinker
1.724360E-02
Normal-vs-Social Drinker
9.587900E-04
Non Drinker-vs-Daily Drinker
3.654800E-01
Non Drinker-vs-Weekly Drinker
8.466200E-01
Non Drinker-vs-Occasional Drinker
1.812240E-01
Non Drinker-vs-Social Drinker
2.396600E-01
Daily Drinker-vs-Weekly Drinker
5.572000E-01
Daily Drinker-vs-Occasional Drinker
6.774100E-02
Daily Drinker-vs-Social Drinker
7.812400E-02
Weekly Drinker-vs-Occasional Drinker
1.645010E-01
Weekly Drinker-vs-Social Drinker
2.454200E-01
Occasional Drinker-vs-Social Drinker
6.948800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
2.166000E-01
Normal-vs-Grade 2
1.058570E-01
Normal-vs-Grade 3
1.190600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.760600E-01
Grade 1-vs-Grade 3
4.318200E-01
Grade 1-vs-Grade 4
2.166000E-01
Grade 2-vs-Grade 3
9.275000E-01
Grade 2-vs-Grade 4
1.058570E-01
Grade 3-vs-Grade 4
1.190600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
1.792820E-04
Normal-vs-NonDiabetic
1.60941999999276E-05
Diabetic-vs-NonDiabetic
7.779200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
9.73939999981965E-07
Normal-vs-NoPancreatitis
5.57729999999257E-05
Pancreatitis-vs-NoPancreatitis
1.520140E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
6.179000E-04
Normal-vs-N1
2.18309999999722E-05
N0-vs-N1
9.490000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
9.87999999999545E-05
Normal-vs-TP53-NonMutant
6.461500E-03
TP53-Mutant-vs-TP53-NonMutant
6.002000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap